Journal of Microbiology and Related Research

Baculoviruses are dsDNA viruses and universally used biological control agents in the integrated pest management
programmes. The foremost drawback of these viruses is their sensitivity towards ultraviolet radiation. Different
materials have been tested by different workers to influence the sunlight protectant activity. Microencapsulation
is currently an extensively studied approach in protecting baculoviruses from UV light as well as enhances the
activity, efficiency and performance of baculoviruses formulations. Findings suggest that the microencapsulation
technique could reduce the cost and enhance the efficacy of baculoviruses. On the other hand, it can also reduce the
use of agrochemicals and their residues in the environment and food materials
 

Background: The treatment of severe P. falciparum Malaria and severe P. vivax Malaria is identical. Their treatment in India is complex because different regimes exist for the North-eastern part of the country and for the rest of the country. Also, different drugs are needed for the treatment of pregnant patients. oBjectives: To find out what are the antimalarials prescribed in India for treating severe Falciparum Malaria and severe Vivax Malaria. Methods: By reviewing documents prepared by NVBDCP. results: It is found that different regimes exist for treating severe Falciparum Malaria and severe Vivax Malaria depending on where the patient comes from, and the drugs differ based on the pregnancy status of the female patient. conclusions: More education is required among health care providers on how to treat severe P. falciparum Malaria and severe P. vivax Malaria. This paper addresses this concern

Background: Uncomplicated P. vivax Malaria treatment in India is straightforward because the same regime exists for the North-eastern part of the country and the rest of the country unlike treating uncomplicated P. falciparum Malaria where different regimes exist for these two areas. However, a slightly different approach is needed for the treatment of pregnant patients. oBjectives: To find out what are the antimalarials prescribed in India for treating uncomplicated Vivax Malaria. Methods: By reviewing documents prepared by WHO and NVBDCP. results: It is found that the same regime exists for treating uncomplicated Vivax Malaria whether the patient comes from any part of the country. However, some modifications are made depending on the pregnancy status of the female patient. conclusions: Some more education is required among health care providers on how to treat uncomplicated P. vivax Malaria. This paper addresses this concern.